Malignant hyperthermia following rhinoplasty: a case report

Message:
Article Type:
Case Report (دارای رتبه معتبر)
Abstract:

Malignant hyperthermia is a rare and fatal disorder. A 16-year-old male patient was a candidate for rhinoplasty surgery with no history of disease and previous surgery, negative family history and no history of medication use in the operating room. Maintenance of anesthesia was performed with O2, NO2 (50% -50%) and MAC isoflurane 1. Gradually, from the 80th minute after the start of the operation, the patient had a tachycardia and the SPO2 began to decrease, reaching 93%, and the ETCO2 increased. While the tachycardia was still present, the patient's temperature rose to 38.5 ° C with a tympanic thermometer. The isoflurane was stopped immediately. Hyperventilation began and Dantrolen was administered at a dose of 2.5 mg / kg. Cooling of the patient began with cold saline infusion and ice gavage and bladder lavage with ice and cooling of the body surface. During this time, the patient's rhythm changed to V.Tack, followed by V.Fib, and finally cardiac arrest. Resuscitation was performed. At 110 minutes after the surgery, the patient's rhythm returned to V.Tak and V.fib, and cardiac arrest occurred, and resuscitation was performed. After 10 minutes, a pulse was established. The patient was transferred to the ICU. About 6 hours after entering the ICU, the patient had cardiac arrest and CPR did not respond and the patient died. According to the results of the above study, the most important point is suspecting the occurrence of this syndrome and also the immediate start of treatment immediately after the onset of symptoms.

Language:
Persian
Published:
Journal of Anesthesiology and Pain, Volume:13 Issue: 1, 2022
Pages:
54 to 59
magiran.com/p2425393  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!